U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249476) titled 'Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia' on Nov. 18.
Brief Summary: The aim of the ENKLA-M study is to collect samples from patients with acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), and myelodysplastic syndrome (MDS) to study the evolution of blast phenotype (NK receptor ligands and adhesion molecules) and the biology of patients' NK cells). To do this, blood and bone marrow samples will be collected from patients at diagnosis in order to characterize: (I) the phenotype of ALL and AML blasts with respect to NK receptor ligands and adhesion molecules; (II) the phenotyp...